Antidote is on a mission to catalyze medical innovation by successfully connecting patients and researchers as the best-in-class recruiter for clinical studies.
Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. We're based in New York, NY and London, U.K. For more information, visit http://www.antidote.me.